BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8065701)

  • 21. Murine herpes simplex virus keratitis is accentuated by CD4+, V beta 8.2+ Th2 T cells.
    Foster CS; Rodriguez Garcia A; Pedroza-Seres M; Berra A; Heiligenhaus A; Soukiasian S; Jayaraman S
    Trans Am Ophthalmol Soc; 1993; 91():325-48; discussion 349-50. PubMed ID: 7908153
    [No Abstract]   [Full Text] [Related]  

  • 22. Herpes simplex virus latency in human cornea.
    Shimomura Y; Mori Y; Inoue Y; Kiritooshi A; Ohashi Y; Manabe R
    Jpn J Ophthalmol; 1993; 37(3):318-24. PubMed ID: 8295371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
    Banerjee K; Biswas PS; Rouse BT
    J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological and immunopathological analysis of T-cells mediating murine HSV-1 keratitis.
    Heiligenhaus A; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):628-34. PubMed ID: 8001832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenicity of glycoprotein C-deficient herpes simplex virus 1 strain TN-1 which encodes truncated glycoprotein C.
    Minagawa H; Liu Y; Yoshida T; Hidaka Y; Toh Y; Mori R
    Microbiol Immunol; 1997; 41(7):545-51. PubMed ID: 9272700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
    Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1.
    Tumpey TM; Elner VM; Chen SH; Oakes JE; Lausch RN
    J Immunol; 1994 Sep; 153(5):2258-65. PubMed ID: 8051423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
    Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
    J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice.
    Keadle TL; Laycock KA; Miller JK; Hook KK; Fenoglio ED; Francotte M; Slaoui M; Stuart PM; Pepose JS
    J Infect Dis; 1997 Aug; 176(2):331-8. PubMed ID: 9237697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
    Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
    Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
    Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis.
    Heiligenhaus A; Li H; Wasmuth S; Bauer D
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):870-7. PubMed ID: 15241613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
    Thomas J; Rouse BT
    J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine expression in murine corneas during recurrent herpetic stromal keratitis.
    Keadle TL; Usui N; Laycock KA; Kumano Y; Pepose JS; Stuart PM
    Ocul Immunol Inflamm; 2001 Sep; 9(3):193-205. PubMed ID: 11815888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2.
    Ghiasi H; Osorio Y; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(2):286-93. PubMed ID: 12441072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent herpetic stromal keratitis in mice: a model for studying human HSK.
    Stuart PM; Keadle TL
    Clin Dev Immunol; 2012; 2012():728480. PubMed ID: 22593769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea.
    Polcicova K; Biswas PS; Banerjee K; Wisner TW; Rouse BT; Johnson DC
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11462-7. PubMed ID: 16055558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.
    Lepisto AJ; Frank GM; Xu M; Stuart PM; Hendricks RL
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3400-9. PubMed ID: 16877409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.